3-year invasive disease-free survival with chemotherapy de-escalation using an (18)F-FDG-PET-based, pathological complete response-adapted strategy in HER2positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
Nature 266:565567 Xu D, Trmulot L, Yang Z, Mhamdi A, Chtel-Innocenti G, Mathieu M, Espinasse C, Van Breusegem F, Vanacker H, Issakidis-Bourguet E, Noctor G (2025) Cytosolic monodehydroascorbate reductase 2 promotes oxidative stress signaling in Arabidopsis
Adamia, S
doi: 10.1111/jgs.17607
Phrases like 'BIENVENIDO AL EQUIPO ELITE' and 'TU DECISIN HABLA DE GRANDEZA' really capture the essence of what it means to join this community
We review your lab work including GH, IGF-1, and metabolic markers, along with your health history and optimization goals